Ravi Majeti, MD, PhD
Professor at Stanford University
2011 NYSCF – Robertson Stem Cell Investigator Alumnus
MD, University of California, San Francisco
PhD, University of California, San Francisco
Postdoctoral Training, Stanford University
Bio
Dr. Majeti is a Professor in the Department of Medicine, Chief of the Division of Hematology, and Member of the Institute for Stem Cell Biology and Regenerative Medicine at Stanford University, where he has focused on finding an alternative strategy of killing cancer stem cells in acute myeloid leukemia (AML), an aggressive type of blood cancer. He has had success in using a treatment where cells target CD47, a protein found on many cancer stem cells, and is now pursuing clinical trials to eradicate cancers like AML. He and his lab aim to not just bring about remission, but also eliminate any relapses in patients. He completed his postdoctoral studies at Stanford University.
External Links
Research Area
Mentioned In
- Our Community’s Top 10 Stem Cell and Neuroscience Breakthroughs of 2023
- New Frontiers in Regenerative Medicine: Highlights of the 2023 NYSCF Conference
- Can Tumor Cells Be Used To Make A Cancer Vaccine?
- NYSCF Innovator Improves Research Model For Blood Cancer
- NYSCF - Robertson Stem Cell Investigator Identifies Mutant Protein Function in Cancer
- NYSCF - Robertson Investigator Changes Leukemia Cells Into Harmless Immune Cells
- NYSCF - Robertson Investigator Works to Understand Leukemia